Correlation Between ProSomnus, Common and MaxCyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ProSomnus, Common and MaxCyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProSomnus, Common and MaxCyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProSomnus, Common Stock and MaxCyte, you can compare the effects of market volatilities on ProSomnus, Common and MaxCyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProSomnus, Common with a short position of MaxCyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProSomnus, Common and MaxCyte.

Diversification Opportunities for ProSomnus, Common and MaxCyte

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between ProSomnus, and MaxCyte is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding ProSomnus, Common Stock and MaxCyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MaxCyte and ProSomnus, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProSomnus, Common Stock are associated (or correlated) with MaxCyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MaxCyte has no effect on the direction of ProSomnus, Common i.e., ProSomnus, Common and MaxCyte go up and down completely randomly.

Pair Corralation between ProSomnus, Common and MaxCyte

Considering the 90-day investment horizon ProSomnus, Common Stock is expected to generate 16.16 times more return on investment than MaxCyte. However, ProSomnus, Common is 16.16 times more volatile than MaxCyte. It trades about 0.05 of its potential returns per unit of risk. MaxCyte is currently generating about -0.01 per unit of risk. If you would invest  490.00  in ProSomnus, Common Stock on September 2, 2024 and sell it today you would lose (443.00) from holding ProSomnus, Common Stock or give up 90.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy82.8%
ValuesDaily Returns

ProSomnus, Common Stock  vs.  MaxCyte

 Performance 
       Timeline  
ProSomnus, Common Stock 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ProSomnus, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ProSomnus, Common is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
MaxCyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MaxCyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

ProSomnus, Common and MaxCyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ProSomnus, Common and MaxCyte

The main advantage of trading using opposite ProSomnus, Common and MaxCyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProSomnus, Common position performs unexpectedly, MaxCyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MaxCyte will offset losses from the drop in MaxCyte's long position.
The idea behind ProSomnus, Common Stock and MaxCyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets